Patent · US Active

Stable dosage form of phenylalanine derivatives

US9089532B2 · kind B2 · utility

6Cited by

0References

1Claims

0Family size

Assignee

Wilex AG · DE

Inventors

Wolfgang Schmalix · Puchheim, DE
Markus Bürgle · Hersbruck, DE
Klaus Koch · Geislingen, DE

Key dates

Filing date	Sep 20, 2005
Grant date	Jul 28, 2015
Priority date	—
Expiry date	Dec 16, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to improved and stable pharmaceutical formulations of phenylalanine derivatives and the use thereof as urokinase inhibitors, particularly for the treatment of malignant tumors and tumoral metastases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.